TechScan

Sonovue

SonoVue is an ultrasound contrast agent originally developed by Bracco. It is characterised by a microbubble structure consisting of a low solubility gas (sulfur hexafluoride) stabilised by a phospholipids shell.

After intravenous injection, it remains in the vascular space and strongly increases the backscatter of ultrasound signals. Therefore, SonoVue is useful in the enhancement of blood echogenicity for the assessment of blood flow in the vasculature.

SonoVue is approved in the following indications:

• Doppler of macrovasculature - Increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid of peripheral arteries by improving the Doppler signal-to-noise ratio. Increases the quality of the Doppler flow image and the duration of clinically-useful signal enhancement in portal vein assessment. (Dosage - 2.4 mL for intravenous administration in bolus).
• oppler of microvasculature - Improves detection of the vascularity of liver and breast lesions during Doppler Sonography, leading to more specific lesion characterization. (Dosage - 2.4 mL for intravenous administration in bolus).
• Echocardiography - A transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation. (Dosage - 2.0 mL for intravenous administration in bolus).

For further details, contact:
i imaging Products India Limited
1 Silver Stone, 294 Linking Road
Khar (W), Mumbai: 52
Tel: 022-2648-5194/2648-8665/ 2648-8619
Fax: 022-2648-5194
Email: ip@imagingproductsindia.com